OS Therapies Incorporated OSTX
1.00 USD +0.02 (+2.03%)
At closeNov 6, 2026, 4:00 PM EST
0.98 -0.02 -2.00%
After hours · Nov 6, 4:00 PM ET
0.8402 Day range 1.00
0.58 52-week range 2.25
- YTD
- -28.57%
- 1 year
- -45.05%
- Market cap
- 46.81M
- EPS (ttm)
- -1.08
- Shares out
- 21.24M
- Forward P/E
- 2.57
- YTD return
- -28.57%
- 1-year return
- -45.05%
- Volume
- 974.54K
- Avg volume
- 666.12K
- Open
- 0.98
- Previous close
- 0.9801
- Day's range
- 0.8402 – 1.00
- 52-week range
- 0.58 – 2.25
- Price target
- 12.67 (+1166.7%)
5D -0.27 (-21.26%)
Key statistics
- Enterprise value
- 62.55M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 94.92K
- Total debt
- 16.70M
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 2.72
- 200-day average
- 3.11
Analyst view
Price target (mean) 12.67 +1166.7% upside
Now 1.00
- Target (low)
- 8.00
- Target (mean)
- 12.67
- Target (high)
- 21.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.14.
Financials — quick view
OSTX Revenue — quarterly 0
OSTX Net income — quarterly -8.63M
OSTX EPS — quarterly -0.20
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 26, 2024 | Maxim Group | init | — | Buy |
| Oct 3, 2024 | EF Hutton | main | Buy | Buy |
| Sep 16, 2024 | EF Hutton | main | Buy | Buy |
| Sep 3, 2024 | EF Hutton | init | — | Buy |
About OS Therapies Incorporated
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- ostherapies.com
News
Your note
Sign in to keep a note on OSTX — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Millennium Management Llc | 0.28% | 60,435 | 228.44K | Sep 29, 2024 |
| CM Management, LLC | 0.24% | 50,000 | 189.00K | Sep 29, 2024 |
| Delta Investment Management, LLC | 0.09% | 18,081 | 68.35K | Sep 29, 2024 |
| HRT Financial LP | 0.08% | 17,576 | 66.44K | Sep 29, 2024 |
| Virtu Financial LLC | 0.05% | 10,045 | 37.97K | Sep 29, 2024 |
| UBS Group AG | 0.02% | 3,806 | 14.39K | Sep 29, 2024 |